Internal Medicine · Baltimore, MD
NPI
1457855025
Since 2018
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1111 N Charles St
Baltimore, MD, 21201
Phone (410) 837-2050
Groups this clinician bills Medicare through
Medicare paid, 2023
$589
52 services
Medicare patients, 2023
25
Average age 63
Drug cost, 2024
$709K
3,514 prescriptions
Company payments, 2025
$18.85
From 1 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Gabrielle D Morris was code 83036 (blood count), 38 times for 20 patients. In total Gabrielle D Morris billed 52 services in 8 codes, and Medicare paid $589.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 83036 Blood Count | Office | 38 | 20 | $9.52 | $362 |
By year: 2022 $668 for 63 services; 2023 $589 for 52 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 38 | 20 | $9.52 | $362 |
Medicare prescription drug claims, 2024
In 2024, the drug Gabrielle D Morris prescribed most often to Medicare patients was Atorvastatin Calcium, with 236 prescriptions and refills. In total Gabrielle D Morris wrote 3,514 Medicare prescriptions that cost $709K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 236 | 511 | 66 | $1,421 |
| Amlodipine Besylate Generic | 139 | 321 | 45 | $571 |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | 124 | 130 | Under 11 | $78K |
| Gabapentin Generic | 115 | 199 | 32 | $2,158 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 110 | 119 | 40 | $3,841 |
| Fluticasone Propionate Generic | 91 | 128 | 24 | $840 |
| Lisinopril Generic | 88 | 166 | 22 | $366 |
| Jardiance Empagliflozin | 76 | 152 | 21 | $87K |
| Ozempic Semaglutide | 72 | 82 | 14 | $75K |
| Omeprazole Generic | 68 | 132 | 21 | $589 |
| Famotidine Generic | 64 | 127 | 24 | $733 |
| Pravastatin Sodium Generic | 60 | 127 | 14 | $624 |
| Rosuvastatin Calcium Generic | 60 | 136 | 20 | $915 |
| Olmesartan Medoxomil Generic | 55 | 102 | 14 | $659 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 53 | 53 | Under 11 | $33K |
Brand drugs: 848 claims; generic drugs: 2,602 claims; opioid claims: 90.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gabrielle D Morris $18.85 ($18.85 in general payments such as food, travel and fees) from 1 company. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $18.85.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.